Incident hypertension, cumulative viral load possibly linked in people with HIV
October 01 ,2022
Overview:Cumulative viral load may be associated with incident hypertension among people with HIV, despite CVD risk factors possibly differing between health care systems, researchers found.Adovich S. Rivera, MD, PhD, postdoctoral research fellow at Kaiser Permanente Southern California, who was a PhD student at Northwestern University Feinberg School of Medicine at the time of the study, and colleagues analyzed 7,628 people with HIV without diabetes at baseline and 7,450 people with HIV without hypertension at baseline.The data were collected from two Chicago health care systems: Northwestern more
Fewer than half of older adults with BP conditions monitor themselves at home
September 30 ,2022
Overview:Fewer than half of people aged 50 to 80 years who take BP medication or have a condition that’s affected by hypertension regularly check their BP at home, a recent study in JAMA Network Open found.According to the CDC, 74.5% of U.S. adults aged 60 years or older had hypertension in 2017 to 2018. Despite guidelines recommending “that patients use self-measured blood pressure monitoring outside the clinic to diagnose and manage hypertension,” the prevalence and frequency of at-home monitoring in the U.S. has been unclear, Mellanie V. Springer, MD, MS, an assistant professor of more
FDA designates recall of pump used in cardiac surgery as class I
September 30 ,2022
Overview:The FDA has designated the recall of a pump used in cardiac surgery as class I, the most serious kind.LivaNova (TandemLife) recalled the LifeSPARC system, which is used for full or partial cardiopulmonary bypass or temporary circulatory bypass in open surgical procedures because of a software malfunction, according to an agency press release.The monitoring feature of the controller may erroneously detect frozen or unresponsive software and trigger critical failure mode, requiring replacement of the controller, according to the release.If during controller replacement, the frozen controller is more
VIDEO: Digital technology can be used to promote health, wellness
September 30 ,2022
Overview:In this Healio video exclusive, David D. McManus, MD, discusses ideas that were exchanged at the Heart Rhythm Society’s inaugural HRX meeting regarding the use of digital technology to promote health and wellness.McManus, professor and chair of the department of medicine at the UMass Chan Medical School and UMass Memorial Health, said the challenge is that “the populations that are most resistant to use of technology are those we need to use them the most in” for changing behaviors such as smoking, alcohol consumption, lack of physical activity and poor sleep habits.“Our more
Dual therapy for lower target LDL after stroke reduces risk for events at 5 years
September 30 ,2022
Overview:An LDL target of less than 70 mg/dL with ezetimibe plus statin therapy was associated with lower risk for subsequent events after stroke/transient ischemic attack at 5 years vs. a target between 90 mg/dL and 110 mg/dL, researchers reported.In addition, ezetimibe plus statin therapy — dual therapy — for a lower target LDL was not associated with increased risk for intracranial bleeding, according to findings of a post hoc analysis of the Treat Stroke to Target trial published in Stroke.“In the lower target group, dual therapy with statin and ezetimibe significantly reduced more
Donor hearts labeled at-risk underused in pediatric vs. adult transplants
September 30 ,2022
Overview:Donor hearts that meet U.S. Public Health Services increased risk criteria are used much more frequently in adults than in children despite similar posttransplant patient survival and an ongoing organ donor shortage, researchers reported.The high discard rate of pediatric donor hearts presents a “major challenge” for children awaiting heart transplant, with 44% of available pediatric donor hearts being discarded in the U.S., Danielle S. Burstein, MD, a pediatric cardiologist with Children’s Hospital of Philadelphia, and colleagues wrote in JAMA Cardiology. A recent survey more
Well-being resources for health care workers ‘woefully inadequate’
September 30 ,2022
Overview:Emotional exhaustion has increased about 10% for all types of health care workers since the beginning of the COVID-19 pandemic, suggesting that current resources are not enough to improve their well-being, according to researchers.“These findings indicate that emotional exhaustion among health care workers, which was problematic before the pandemic, has become worse; increases in emotional exhaustion may jeopardize care quality and necessitate additional support for the workforce,” J. Bryan Sexton, PhD, an associate professor in psychiatry and behavioral sciences at Duke more
Some patients with AF have fears about diagnosis, but many are not treated promptly
September 29 ,2022
Overview:In a survey conducted for Atrial Fibrillation Awareness Month, researchers found that more than one-quarter of adults with AF have fears about their diagnosis, but many do not feel the urgency to get treated immediately.Among adults aged 55 years or older from the general population, a majority were aware of AF, but most had not spoken to their doctor about it, according to the survey.The survey, sponsored by Biosense Webster, which included 101 patients with AF aged 18 years or older and 1,000 adults from the general population aged 55 years or older, was conducted as a way to gauge more
Empagliflozin HF benefits consistent across albumin levels: EMPEROR-Pooled
September 29 ,2022
Overview:In adults with HF, empagliflozin was associated with a reduction in new macroalbuminuria in patients with macroalbuminuria at baseline compared with placebo.Empagliflozin (Jardiance, Boehringer Ingelheim/Eli Lilly) was also associated with an increase in rate of remission to sustained normoalbuminuria or microalbuminuria.In a secondary analysis of the EMPEROR-Pooled trial , researchers also found that the observed association of empagliflozin with CV and kidney outcomes in people with HF was consistent across albumin-to-creatinine ratio categories.“This study confirms that albuminuria more
Extracardiac vascular disease may drive worse outcomes after PCI
September 29 ,2022
Overview:In adults who undergo PCI, concomitant extracardiac vascular disease is associated with worse clinical outcomes, including all-cause death, regardless of the organ involved and the number of vascular beds, researchers reported.“Extracardiac vascular disease can contribute to increased morbidity and technical challenges for diagnosis and treatment of patients with coronary disease, especially those being considered for revascularization because of factors including vascular access, renal function, frailty and neurologic sequelae,” Mamas A. Mamas, DPhil, MRCP, professor of more
Top news of TCT 2022: PCI vs. CABG in multivessel CAD, PROTECTED TAVR results and more
September 29 ,2022
Overview:Healio and Cardiology Today have compiled a list of the most-read news in CV intervention from TCT 2022.Readers were most interested in the long-term findings from the BEST trial; a trial of two transcatheter mitral valve repair systems for degenerative mitral regurgitation; cerebral embolic protection during transcatheter aortic valve replacement; and more.At a median follow-up of 11.8 years, most outcomes did not differ between PCI with an everolimus-eluting stent and CABG in patients with multivessel CAD, according to new data from the BEST trial. Read moreA novel mitral valve more
Anemia correlates with cardiovascular disease, lower eGFR, additional adverse outcomes
September 28 ,2022
Overview:Anemia independently correlated with lower eGFR and an increased risk of end-stage kidney disease, cardiovascular disease, coronary heart disease, stroke, heart failure and death, according to recently published data.“Iron deficiency is a common cause of anemia and, although it is recommended that all chronic kidney disease patients with anemia be screened and treated for iron deficiency, it is unclear how often this is occurring in practice,” Danielle K. Farrington, MD, MHS, from the division of nephrology in the department of medicine at Johns Hopkins University School of more
Long-term P2Y12 inhibitor monotherapy after PCI reduces bleeding at 3 years vs. DAPT
September 28 ,2022
Overview:Long-term P2Y12 inhibition after PCI reduced bleeding at 3 years compared with dual antiplatelet therapy, with no significant differences observed for ischemic events, according to new data from the SMART-CHOICE trial.“In this 3-year follow-up of a randomized clinical trial, P2Y12 inhibitor monotherapy after 3 months of DAPT was found to be comparable with prolonged DAPT for preventing ischemic events. Furthermore, P2Y12 inhibitor monotherapy resulted in a significantly lower rate of major bleeding for up to 3 years,” Ki Hong Choi, MD, of the division of cardiology in the more
AI-guided, targeted screening can detect undiagnosed AF in high-risk adults
September 28 ,2022
Overview:An artificial intelligence algorithm applied to existing ECGs in adults at high risk for stroke can identify signatures of atrial fibrillation risk during normal sinus rhythm, researchers reported in The Lancet.“Atrial fibrillation is common and it is probably underdiagnosed, and there are people for whom the first manifestation of their AF is stroke,” Peter A. Noseworthy, MD, cardiac electrophysiologist at Mayo Clinic, told Healio. “That is a missed opportunity. We would like to find ways to identify people who have subclinical AF who have this impending risk for more
Healio partners with CMHC for annual congress in Boston
September 28 ,2022
Overview:As a valued ally in delivering the latest news, resources and education to busy medical providers, Healio has committed its support to the 17th Annual Cardiometabolic Health Congress: The Present and Future of Cardiometabolic Health.Together with Healio, CMHC will welcome providers across many medical specialties to learn from pioneers and visionaries in the cardiometabolic health movement.Taking place at the downtown Boston Park Plaza from Oct. 19 to 22, the 17th Annual CMHC is a 4-day conference featuring didactic lectures, interactive sessions, expert panel debates, audience Q&As and more
Forward-solution computational ECG mapping system may enhance arrhythmia therapies
September 28 ,2022
Overview:In the VMAP study, a noninvasive forward-solution computational ECG mapping system met accuracy goals for arrhythmia and pacing localization, suggesting a role for its use in targeted arrhythmia therapies, researchers reported.The researchers conducted the study to determine whether the mapping system (vMap, Vektor Medical), which can rapidly map cardiac arrhythmias using only 12-lead ECG data, would be accurate at identifying arrhythmia sources in the heart.As Healio previously reported, the system received FDA clearance in November 2021.“The most common way we map arrhythmias is more
Similar safety, efficacy with 90 W vs. 50 W radiofrequency ablation for AF
September 28 ,2022
Overview:Very high-powered short-duration radiofrequency ablation for atrial fibrillation with 90 W using a next-generation catheter was safe and effective vs. high-powered short-duration 50 W radiofrequency ablation, researchers reported.“Although point-by-point catheter ablation is the method of choice for flexible lesion sets for both pulmonary vein isolation and extra-pulmonary vein ablations, individual lesion generation can drive long ablation, fluoroscopy and procedure times,” Julian Müeller, MD, of the Clinic for Interventional Electrophysiology, Heart Centre Bad Neustadt, Germany, more
Women more likely than men to have adverse events after AF ablation
September 27 ,2022
Overview:Among patients who had catheter ablation for atrial fibrillation, women were more likely than men to require hospitalization for more than 1 day, to have major adverse events and to have poor quality of life outcomes, researchers reported.Reed Mszar, MPH, researcher in the Center for Outcomes Research and Evaluation at Yale-New Haven Hospital, and colleagues conducted an observational cohort study of 58,960 adults (34.6% women) who had catheter ablation for AF from 2016 to September 2020 and were included in the National Cardiovascular Data Registry AFib Ablation Registry to determine whether more
Despite recommendations, statin use ‘not ubiquitous’ in CKD with ASCVD
September 27 ,2022
Overview:Overall statin use among adults with chronic kidney disease is high, yet there have been only modest increases in the use of high‐intensity statins, ezetimibe and PCSK9 inhibitors, data from a prospective 2‐year study show.Both the 2013 Kidney Disease: Improving Global Outcomes (KDIGO) and 2018 American College of Cardiology/American Heart Association cholesterol guidelines recommend at least statin therapy for adults with non‐dialysis-dependent chronic kidney disease (CKD) and atherosclerotic CVD, as CKD is a major risk factor for disease progression, Robert S. Rosenson, MD, director of more
Poor medication adherence tied to CV events, all-cause death in CAD
September 27 ,2022
Overview:Data from a meta-analysis show that a 20% improvement in CV medication adherence could reduce risk for any CV event by 8% and risk for all-cause mortality by 12% among patients with CAD, researchers reported.“Medication adherence has been defined as the extent to which a patient takes medications as prescribed by their health care providers,” Kui Hong, MD, PhD, of the department of cardiovascular medicine at the Second Affiliated Hospital of Nanchang University in Jiangxi, China, and colleagues wrote in Clinical Cardiology. “In clinical practice, medication nonadherence is more
Optimal Antiplatelet Therapy In NSTE-ACS: Results From A Novel Crowdsourcing Survey
July 07 ,2021
Overview:The choice and duration of antiplatelet therapy in NSTE-ACS undergoing PCI is complex and is a hotly debated topic – particularly amongst patients at high bleeding risk. To gain insight […] more
Results of an international crowdsourcing survey on the utilisation of antiplatelet therapy in NSTE-ACS
June 09 ,2021
Overview:Choosing an antiplatelet strategy in patients with non-ST segment elevation acute coronary syndrome (NSTE-ACS) at high bleeding risk (HBR), undergoing percutaneous coronary intervention (PCI), is complex given that one must […] more
Hello world!
February 04 ,2021
Overview:Welcome to WordPress. This is your first post. Edit or delete it, then start writing! The post Hello world! appeared first on World Heart Federation. more
ACC.20/WCC Virtual continues!
April 05 ,2020
Overview:The World Heart Federation and American College of Cardiology held their first ever virtual congress March 28-30. But it’s not over. All of the ACC.20/WCC Virtual live sessions are now available […] more
2020 ISCP Annual Meeting cancelled
February 26 ,2020
Overview:Notice of Cancellation We regret to have to inform our colleagues and friends that the 2020 ISCP Annual Scientific Meeting in Miami will now be cancelled. The Board of Directors […] more
European Cardiology Review (ECR) now on PubMed and PubMed Central
October 30 ,2018
Overview: European Cardiology Review (ECR) confirms that it has been accepted for indexing on PubMed Central and PubMed. All ECR articles starting from the first issue in July 2014, […] more
WHF to attend the WHO Executive Board meeting in January 2017
January 23 ,2017
Overview:From 23 January to 01 February 2017, the World Health Organization(WHO) will host the 140th session. From 23 January to 01 February 2017, the World Health Organization(WHO) will host the […] more